Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Return on Capital Employed (2018 - 2025)

Crinetics Pharmaceuticals (CRNX) has 8 years of Return on Capital Employed data on record, last reported at 0.48% in Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 18.0% year-over-year to 0.48%; the TTM value through Dec 2025 reached 0.48%, down 18.0%, while the annual FY2025 figure was 0.43%, 8.0% down from the prior year.
  • Return on Capital Employed reached 0.48% in Q4 2025 per CRNX's latest filing, down from 0.41% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.28% in Q1 2025 and bottomed at 0.71% in Q2 2023.
  • Average Return on Capital Employed over 5 years is 0.42%, with a median of 0.4% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: tumbled -32bps in 2023, then skyrocketed 40bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.41% in 2021, then dropped by -21bps to 0.49% in 2022, then increased by 24bps to 0.37% in 2023, then increased by 20bps to 0.3% in 2024, then crashed by -60bps to 0.48% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.48% in Q4 2025, 0.41% in Q3 2025, and 0.34% in Q2 2025.